Compare Amphastar Pharmaceuticals Inc (AMPH) vs iShares TIPS Bond ETF (TIP) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

TIP trades at $108.13 with minimal daily movement, showing a 0.01% gain. Technical indicators signal a bearish trend with moving averages unanimously negative, though oscillators remain neutral. The stock faces significant selling pressure with 17 sell signals versus 5 buy signals. Recent corporate actions include scheduled dividend payments of $1.28 in June 2026 and $1.06 in July 2026, providing income appeal despite the weak technical picture.

The outlook remains cautious given the bearish technical momentum and absence of current fundamental data. Dividend payments offer some support, but the stock requires monitoring for fundamental updates and potential technical reversal signals before establishing a bullish position. Market sentiment reflects broader bond market uncertainties and Federal Reserve policy concerns.